Here's what workplaces young professionals are the most happy. Photo via Getty Images

Ten businesses in the Greater Houston area are clocking in among the country's best employers for millennials, according to a new report.

The Best Workplaces for Millennials list is published annually by Fortune magazine and compiled by Great Place to Work, a company that focuses on improving workplace culture.

Looking at the 10 Houston-area employers, mega developer David Weekley homes takes the top spot. The company appears at No. 12 on the list of large employers.

"It's an honor to once again be recognized as a top company for working millennials," said Robert Hefner, David Weekly vice president of human resources, in a statement. "We are very proud to offer a rewarding workplace culture as well as competitive benefits and amazing perks to draw this group of young talent to our award-winning team."

In that survey, 97 percent of staffers called David Weekley Homes a great place to work. The home builder previously ranked at number 26 on the 2020 list.

Joining David Weekly on the list are these large, mid-size, and small Houston-area companies:

Large employers:

  • Camden Property Trust, No. 32
  • Hilcorp, No. 37
  • Cornerstone Home Lending, No. 38
  • Transwestern, No. 65
  • Hewlett Packard Enterprise, No. 95

Small and mid-sized employers:

  • Continued, No. 33
  • Venterra Realty, No. 49
  • Republic State Mortgage, No. 90
  • E.A.G. Services, No. 91

Here's how employers in Texas' other major metro areas fared.

Dallas

  • Plano-based Granite: No. 6
  • Addison-based Credera, No. 36
  • Dallas-based Pariveda Solutions, No. 76
  • Dallas-based Embark, No. 97
  • Dallas-based PrimeLending lands at No. 29
  • Dallas-based Ryan LLC at No. 35.

Austin

Large employers:

  • Round Rock-based Dell Technologies, No. 75

Small and mid-sized employers:

  • Austin-based OJO Labs, No. 51
  • Austin-based SailPoint, No. 60
  • Austin-based Sedera Health, No. 69
  • Austin-based The Zebra, No. 86

San Antonio

Large employers:

  • San Antonio-based NuStar Energy, No. 91
  • San Antonio-based USAA, No. 98

"The Best Workplaces for Millennials treat their employees like people, not just employees," says Michael Bush, CEO of Great Place to Work. "These companies foster caring and respect for one another, at every level of the organization. The result is millennial employees who say they look forward to coming to work and — as our research says — are 50 times more likely to stay a long time."

------

This article originally ran on CultureMap.

Carrie Colbert saw an opportunity is funding female-founded companies, and she's taking it. Photo courtesy of Curate Capital

Houston investor goes all in on funding female founders

HOUSTON INNOVATORS PODCAST EPISODE 81

Carrie Colbert wasn't planning on becoming a venture capital investor — it just happened organically.

"This has been kind of a backwards process. Our fund was driven by demand," Colbert, founder and general partner of Houston-based Curate Capital, says on this week's episode of the Houston Innovators Podcast. "We were getting such good deal flow in terms of quantity and quality."

Colbert says she originally carved out a practical career and worked her way up the corporate ladder within the energy industry — first at Anadarko Petroleum and then at Hilcorp Energy Co. — for almost 20 years. On the side, she was also establishing herself as a prominent content creator specializing in all things colorful on her blog and Instagram.

It was through the network she created that she started learning about up-and-coming businesses that she wanted to get involved in — first as an angel investor for a few years and now through her VC.

"Instagram turned out to be one of the best networking tools for me," Colbert says. "You can connect with people wherever they are and wherever you are."

A prime example of this interaction was Jordan Jones, founder and CEO of Austin-based consumer goods company, Packed Party. Jones suggested meeting up with Colbert, and the two hit it off. Down the road when it came time to fundraise, Colbert became Jones' first outside investor.

"I've never had to search for deals," Colbert says. "I connect with them on social media or, in pre-pandemic days, I meet them at creative conferences."

Now, under her Curate Capital, Colbert is raising an initial $10 million fund — and she's already committed about 40 percent of that into companies across industries — consumer packaged goods, fintech, health tech, and more.

"We are not industry specific," Colbert says. "Rather, where I have found our sweet spot to be is businesses by women, for women... That's where I think I can provide the most value."

Female founders continue to be funded less than their male counterparts, and Crunchbase reported that last year the discrepancy increased drastically. Colbert recognizes this need and carved out her niche accordingly.

"Women control so much of the spending, and yet are getting so few of the VC dollars. We really see that as an opportunity. It's not a problem we're trying to fix necessarily — we certainly can't rectify it on our own," Colbert says.

Colbert expects her first fund's initial close around July, and she also plans on announcing new investments in the next few weeks. She's also working on bringing on new limited partners and will soon be launching a crowdfunding opportunity to get more women in her network involved.

Colbert shares more about Curate Capital and her advice for her fellow female entrepreneurs on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston family's $20M donation drives neurodegeneration research

big impact

Neurodegeneration is one of the cruelest ways to age, but one Houston family is sharing its wealth to invigorate research with the goal of eradicating diseases like Alzheimer’s.

This month, Laurence Belfer announced that his family, led by oil tycoon Robert Belfer, had donated an additional $20 million to the Belfer Neurodegeneration Consortium, a multi-institutional initiative that targets the study and treatment of Alzheimer’s disease.

This latest sum brings the family’s donations to BNDC to $53.5 million over a little more than a decade. The Belfer family’s recent donation will be matched by institutional philanthropic efforts, meaning BNDC will actually be $40 million richer.

BNDC was formed in 2012 to help scientists gain stronger awareness of neurodegenerative disease biology and its potential treatments. It incorporates not only The University of Texas MD Anderson Cancer Center, but also Baylor College of Medicine, Massachusetts Institute of Technology (MIT) and Icahn School of Medicine at Mount Sinai.

It is the BNDC’s lofty objective to develop five new drugs for Alzheimer’s disease and related disorders over the next 10 years, with two treatments to demonstrate clinical efficacy.

“Our goal is ambitious, but having access to the vast clinical trial expertise at MD Anderson ensures our therapeutics can improve the lives of patients everywhere,” BNDC Executive Director Jim Ray says in a press release. “The key elements for success are in place: a powerful research model, a winning collaborative team and a robust translational pipeline, all in the right place at the right time.”

It may seem out of place that this research is happening at MD Anderson, but scientists are delving into the intersection between cancer and neurological disease through the hospital’s Cancer Neuroscience Program.

“Since the consortium was formed, we have made tremendous progress in our understanding of the molecular and genetic basis of neurodegenerative diseases and in translating those findings into effective targeted drugs and diagnostics for patients,” Ray continues. “Yet, we still have more work to do. Alzheimer's disease is already the most expensive disease in the United States. As our population continues to age, addressing quality-of-life issues and other challenges of treating and living with age-associated diseases must become a priority.”

And for the magnanimous Belfer family, it already is.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes a podcast with the founder of a new venture firm, a former astronaut and recent award recipient, and a health care innovator with fresh funding.

Zach Ellis, founder and managing partner of South Loop Ventures

Zach Ellis explains on the Houston Innovators Podcast that South Loop Ventures plans to invest in promising companies from across the country and bring them into Houston's ecosystem to grow and scale. Photo via LinkedIn

Houston has a lot of the right ingredients for commercialization and scaling up companies, so when Zach Ellis moved to town to stand up a venture capital firm that made investments in diverse founders, he decided to go about it in an innovative way.

South Loop Ventures, which Ellis launched two years ago, invests in pre-seed and seed-stage startups across health care, climatetech, aerospace, sports, and fintech. While the first handful of investments, which have already been made, are into Houston-based companies, Ellis explains on the Houston Innovators Podcast that the firm plans to invest in promising companies from across the country and bring them into Houston's ecosystem to grow and scale.

"Any investor wants to feel like they are looking at the best possible investment opportunities in which to deploy capital," Ellis says on the show. "So that's reason No. 1 to cast your net as widely as possible.

"At the same time, you want to give any investment that you make greatest chances of success," he continues. "The biggest factor of success outside of the team and the capital you give them, is the customers that they can call upon. In bringing targeted companies to Houston or connecting them with Houston, you introduce the opportunity for them to achieve rapid scale and work with world-class partners very efficiently." Read more.


Toby R. Hamilton, founder and CEO of Hamilton Health Box

Dr. Toby Hamilton has secured $10 million to grow his company. Photo via tmc.edu

A Houston company that is working on a value-based model for primary care has fresh funding to support its mission.

Hamilton Health Box announced the completion of a $10 million series A funding round led by 1588 Ventures with participation from Memorial Hermann Health System, Impact Ventures by Johnson & Johnson Foundation, Texas Medical Center Venture Fund, and the Sullivan Brothers.

The company, founded in 2019 by Dr. Toby R. Hamilton, will use the funding to fuel its expansion into rural areas to help assist those living in Health Professional Shortage Areas, or HPSAs. Read more.

Ellen Ochoa, former astronaut and center director at the NASA's Johnson Space Center

Ellen Ochoa was recognized for her leadership at NASA Johnson and for being the first Hispanic woman in space. Photo via NASA

Two astronauts recently received Presidential Medals of Freedom from President Joe Biden for their leadership in space.

Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby, senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3.

Ochoa spent 30 years with NASA, which included being the 11th director of JSC, deputy center director of JSC, and director of Flight Crew Operations. She served on the nine-day STS-56 mission aboard the space shuttle Discovery in 1993, and became the first Hispanic woman in space. She flew four more times to space with STS-66, STS-96, STS-110, and more.

“I’m so grateful for all my amazing NASA colleagues who shared my career journey with me,” Ochoa says in a NASA news release. Read more.

Houston health care institutions receive $22M to attract top recruits

coming to Hou

Houston’s Baylor College of Medicine has received a total of $12 million in grants from the Cancer Prevention & Research Institute of Texas to attract two prominent researchers.

The two grants, which are $6 million each, are earmarked for recruitment of Thomas Milner and Radek Skoda. The Cancer Prevention & Research Institute of Texas (CPRIT) announced the grants May 14.

Milner, an expert in photomedicine for surgery and diagnostics, is a professor of surgery and biomedical engineering at the Beckman Laser Institute & Medical Clinic at the University of California, Irvine and the university’s Chao Family Comprehensive Cancer Center

In 2013, Milner was named Inventor of the Year by the University of Texas at Austin. At the time, he was a professor of biomedical engineering at UT. One of his major achievements is co-development of the MasSpec Pen, a handheld device that identifies cancerous tissue within 10 seconds during surgical procedures.

Skoda is a professor of molecular medicine in the Department of Biomedicine at the University of Basel and the University Hospital Basel, both in Switzerland. He specializes in developing treatments for myeloproliferative neoplasms, which are a group of blood diseases including leukemia.

Other recruitment grants provided by the institute to Houston-area organizations are:

  • $4 million for recruitment of Susan Bullman to the University of Texas M.D. Anderson Cancer Center. She was an assistant professor at Seattle’s Fred Hutchinson Cancer Center, where she studied the connection between microbes and cancer.
  • $4 million for recruitment of Oren Rom to the University of Texas M.D. Anderson Cancer Center. Rom is an assistant professor of pathology and translational pathobiology at Louisiana State University Shreveport.
  • Nearly $2 million for recruitment of Lauren Hagler to conduct RNA cancer biology at Texas A&M University. She is a postdoctoral scholar in biochemistry at Stanford University.

The institute also awarded grants to five companies in the Houston area:

  • $4.7 million to 7 Hills Pharma for development of immunotherapies to treat cancer and prevent infectious diseases.
  • $4.5 million to Indapta Therapeutics for the Phase 1 trial of a cell therapy for treatment of multiple myeloma and non-Hodgkin’s lymphoma.
  • $2.75 million to Bectas Therapeutics for development of antibodies and biomarkers to overcome a type of resistance T-cell checkpoint therapy.
  • $2.69 million to MS Pen Technologies for development of technology that differentiates between normal tissue and cancerous tissue during surgery.
  • $2.58 million to Crossbridge Bio for development of an antibody-drug combination to treat certain solid tumors.